These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3321740)

  • 21. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
    Belcaro G; Rulo A; Candiani C
    Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
    Stegmann W; Hubner K; Deichmann B; Muller B
    Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 24. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
    Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
    Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of radiation-induced skin reactions in breast cancer].
    Pischnamazzadeh M
    Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative clinical trial of graduated compression stockings and O-(beta-hydroxyethyl)-rutosides (HR) in the treatment of patients with chronic venous insufficiency.
    Neumann HA; van den Broek MJ
    Z Lymphol; 1995 Aug; 19(1):8-11. PubMed ID: 7571793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduction of radiation-induced early skin damage (mouse foot) by O-(beta-hydroxyethyl)-rutoside (author's transl)].
    Fritz-Niggli H; Fröhlich E
    Rofo; 1980 Sep; 133(3):316-21. PubMed ID: 6451559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
    Juon M; Messelhäuser I
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
    [No Abstract]   [Full Text] [Related]  

  • 31. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 33. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography.
    Broks PD
    AJR Am J Roentgenol; 1977 Feb; 128(2):263-5. PubMed ID: 401613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies of Ercevit fort (author's transl)].
    Aoun R
    Sem Hop; 1978 Nov 8-15; 54(37-40):1189-90. PubMed ID: 217103
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy].
    Sohn C; Jähnichen C; Bastert G
    Zentralbl Gynakol; 1995; 117(4):190-7. PubMed ID: 7778354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
    Kienzler JL; Sallin D; Schifflers MH; Ghika A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):395-402. PubMed ID: 12242598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
    Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
    J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
    MacLennan WJ; Wilson J; Rattenhuber V; Dikland WJ; Vanderdonckt J; Moriau M
    Gerontology; 1994; 40(1):45-52. PubMed ID: 8034203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.